Security
TransMedics Group, Inc. Common Stock · TMDX
TMDXNASDAQCommon stockCurrentCIK 1756262Updated Nov 2, 2026
TMDX price & chart
Loading TradingView…
NASDAQ:TMDX on TradingView ↗About the company
TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
In the news
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX ↗
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX ↗
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 946,032,000Source | 785,571,000Source | 1,464,396,000Source | 890,522,000Source | 758,577,000Source | 1,434,820,000Source | 837,530,000Source | 723,831,000Source | 1,068,373,000Source | 804,076,000Source | 706,047,000Source | 277,147,000Source |
| Property, Plant and Equipment, NetUSD | 313,022,000Source | 271,739,000Source | 365,302,000Source | 312,255,000Source | 229,030,000Source | 361,571,000Source | 311,244,000Source | 214,421,000Source | 327,656,000Source | 285,970,000Source | 173,941,000Source | 19,223,000Source |
| GoodwillUSD | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,990,000Source | 11,549,000Source | 11,549,000Source | 11,990,000Source | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,999,000Source | 2,202,000Source | 0Source | 2,050,000Source | 2,253,000Source | 0Source | 2,101,000Source | 2,303,000Source | 1,948,000Source | 2,152,000Source | 2,354,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 330,094,000Source | — | — | 362,751,000Source | — | — | 350,217,000Source | — | — | 394,812,000Source | 201,182,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 80,702,000Source | 90,128,000Source | 104,138,000Source | 104,851,000Source | 81,158,000Source | 90,727,000Source | 142,026,000Source | 81,942,000Source | 84,282,000Source | 97,722,000Source | 63,576,000Source | 27,611,000Source |
| Inventory, NetUSD | 44,506,000Source | 52,152,000Source | 54,137,000Source | 38,868,000Source | 48,671,000Source | 49,890,000Source | 43,380,000Source | 48,541,000Source | 48,881,000Source | 46,554,000Source | 44,235,000Source | 20,605,000Source |
| Assets, CurrentUSD | 612,996,000Source | 492,475,000Source | 651,124,000Source | 558,129,000Source | 509,265,000Source | 619,280,000Source | 505,918,000Source | 488,306,000Source | 637,783,000Source | 497,216,000Source | 510,654,000Source | 252,294,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 21,614,000Source | 20,101,000Source | 20,174,000Source | 13,835,000Source | 16,685,000Source | 16,924,000Source | 10,369,000Source | 7,606,000Source | 16,254,000Source | 16,290,000Source | 8,031,000Source | 2,896,000Source |
| Operating Lease, Right-of-Use AssetUSD | 5,740,000Source | 6,943,000Source | 4,646,000Source | 5,818,000Source | 5,896,000Source | 4,858,000Source | 6,007,000Source | 6,226,000Source | 5,155,000Source | 6,481,000Source | 6,546,000Source | 5,130,000Source |
| Other Assets, NoncurrentUSD | 226,000Source | 163,000Source | 2,188,000Source | 221,000Source | 84,000Source | 2,103,000Source | 211,000Source | 85,000Source | 239,000Source | 208,000Source | 62,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 590,832,000Source | 575,651,000Source | 946,343,000Source | 572,421,000Source | 568,683,000Source | 940,813,000Source | 571,222,000Source | 564,360,000Source | 595,273,000Source | 575,473,000Source | 568,845,000Source | 89,772,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 738,432,000Source | 685,251,000Source | 774,216,000Source | 725,655,000Source | 669,445,000Source | 764,640,000Source | 709,194,000Source | 651,161,000Source | 750,926,000Source | 697,208,000Source | 641,106,000Source | 666,277,000Source |
| Retained Earnings (Accumulated Deficit)USD | -383,333,000Source | -475,098,000Source | -255,953,000Source | -407,652,000Source | -479,314,000Source | -270,635,000Source | -442,559,000Source | -491,508,000Source | -277,950,000Source | -468,241,000Source | -503,705,000Source | -478,677,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 101,000Source | -233,000Source | -210,000Source | 98,000Source | -237,000Source | 2,000Source | -327,000Source | -182,000Source | 124,000Source | -364,000Source | -199,000Source | -225,000Source |
| Stockholders' Equity Attributable to ParentUSD | 355,200,000Source | 209,920,000Source | 518,053,000Source | 318,101,000Source | 189,894,000Source | 494,007,000Source | 266,308,000Source | 159,471,000Source | 473,100,000Source | 228,603,000Source | 137,202,000Source | 187,375,000Source |
| Liabilities and EquityUSD | 946,032,000Source | 785,571,000Source | 1,464,396,000Source | 890,522,000Source | 758,577,000Source | 1,434,820,000Source | 837,530,000Source | 723,831,000Source | 1,068,373,000Source | 804,076,000Source | 706,047,000Source | 277,147,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 79,721,000Source | 60,048,000Source | 98,283,000Source | 56,620,000Source | 54,329,000Source | 91,920,000Source | 55,603,000Source | 50,223,000Source | 89,305,000Source | 59,913,000Source | 54,934,000Source | 23,661,000Source |
| Operating Lease, Liability, CurrentUSD | 3,238,000Source | 2,543,000Source | 3,646,000Source | 3,021,000Source | 2,139,000Source | 3,508,000Source | 2,791,000Source | 2,086,000Source | 3,310,000Source | 2,727,000Source | 2,035,000Source | 1,444,000Source |
| Accounts Payable, CurrentUSD | 12,162,000Source | 13,134,000Source | 12,909,000Source | 9,539,000Source | 13,027,000Source | 11,151,000Source | 10,595,000Source | 9,225,000Source | 10,350,000Source | 10,292,000Source | 12,717,000Source | 3,341,000Source |
| Operating Lease, Liability, NoncurrentUSD | 4,426,000Source | 7,072,000Source | 2,411,000Source | 4,912,000Source | 6,603,000Source | 2,883,000Source | 5,521,000Source | 7,161,000Source | 3,577,000Source | 6,249,000Source | 7,707,000Source | 7,415,000Source |
| Additional Financial Items | ||||||||||||
| Long-term Debt, Current MaturitiesUSD | 5,000,000Source | — | 20,000,000Source | — | — | 15,000,000Source | — | — | 10,000,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 58,696,000Source |
| Other Liabilities, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 7,315,000Source | 25,682,000Source | 190,291,000Source | 35,464,000Source | -25,028,000Source | -36,231,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 11,864,000Source | 6,137,000Source | 27,185,000Source | 19,758,000Source | 8,177,000Source | 3,478,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 9,952,000Source | 8,958,000Source | 36,861,000Source | 33,224,000Source | 19,791,000Source | 10,321,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 6,520,000Source | 44,134,000Source | -13,950,000Source | 34,310,000Source | 33,816,000Source | 21,678,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 3,896,000Source | -2,003,000Source | 7,716,000Source | 8,353,000Source | 28,092,000Source | 8,024,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,126,000Source | 781,000Source | -19,000Source | -1,396,000Source | 6,957,000Source | -3,270,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 1,067,000Source | — | -83,543,000Source | — | -1,660,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 24,533,000Source | -2,855,000Source | 192,840,000Source | 48,803,000Source | -13,028,000Source | -45,817,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -36,657,000Source | -27,038,000Source | -59,251,000Source | -129,303,000Source | -193,953,000Source | 54,513,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 36,657,000Source | 27,038,000Source | 59,251,000Source | 129,744,000Source | 151,847,000Source | 11,907,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 138,000Source | — | 138,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,762,000Source | 3,028,000Source | 16,857,000Source | 22,874,000Source | 400,418,000Source | 167,927,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 36,050,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -8,689,000Source | -26,507,000Source | 151,716,000Source | -58,162,000Source | 193,630,000Source | 175,602,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 466,674,000Source | 330,594,000Source | 491,113,000Source | 401,075,000Source | 480,177,000Source | 310,643,000Source | 488,866,000Source | 337,150,000Source | 395,312,000Source | 201,682,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 10,702,000Source | 11,297,000Source | 8,089,000Source | 3,260,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 1,147,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -327,000Source | 358,000Source | 1,270,000Source | -536,000Source | 193,000Source | -1,021,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 9,136,000Source | 7,944,000Source | 8,606,000Source | 9,372,000Source | 9,952,000Source | 8,958,000Source | 36,861,000Source | 33,224,000Source | 19,791,000Source | 10,321,000Source |
| Amortization of Intangible AssetsUSD | — | — | 100,000Source | 100,000Source | — | 100,000Source | — | 100,000Source | 200,000Source | 200,000Source | 100,000Source | — |
| Capitalized Computer Software, AmortizationUSD | — | — | 400,000Source | — | 800,000Source | 400,000Source | 700,000Source | 0Source | 1,300,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | -486,000Source | 573,000Source | 1,622,000Source | -665,000Source | 342,000Source | -1,129,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | -80,000Source | -80,000Source | -17,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | — | -575,000Source |
| GoodwillUSD | — | — | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,549,000Source | 11,990,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Income Tax Expense (Benefit)USD | — | — | -1,288,000Source | 29,000Source | 4,723,000Source | 1,275,000Source | 1,170,000Source | 994,000Source | -82,769,000Source | 316,000Source | -1,700,000Source | — |
| InterestExpenseNonoperatingUSD | — | — | 3,491,000Source | 3,617,000Source | 7,225,000Source | 3,476,000Source | 7,170,000Source | 3,461,000Source | 13,782,000Source | 14,409,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 24,319,000Source | 4,216,000Source | 14,682,000Source | 34,907,000Source | 7,315,000Source | 25,682,000Source | 190,291,000Source | 35,464,000Source | -25,028,000Source | -36,231,000Source |
| Nonoperating Income (Expense)USD | — | — | -269,000Source | 322,000Source | -4,331,000Source | -385,000Source | -4,812,000Source | -767,000Source | -1,061,000Source | -1,716,000Source | 2,056,000Source | -4,728,000Source |
| Operating ExpensesUSD | — | — | 61,275,000Source | 56,922,000Source | 89,462,000Source | 60,022,000Source | 87,864,000Source | 60,785,000Source | 254,223,000Source | 224,585,000Source | 182,820,000Source | 96,709,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 12,847,000Source | -1,002,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 58,509,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 2,212,000Source | 1,742,000Source | 13,746,000Source | 20,813,000Source | 6,155,000Source | 4,667,000Source |
| AssetAcquisitionContingentConsiderationLiability | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 143,823,000Source | 108,761,000Source | 189,948,000Source | 157,370,000Source | 173,933,000Source | 143,537,000Source | 605,494,000Source | 441,540,000Source | 241,623,000Source | 93,459,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 46,015,000Source | 42,656,000Source | 57,830,000Source | 44,088,000Source | 62,985,000Source | 43,625,000Source | 185,168,000Source | 168,617,000Source | 119,553,000Source | 69,897,000Source |
| Operating Income (Loss)USD | — | — | 23,300,000Source | 3,923,000Source | 23,736,000Source | 36,567,000Source | 13,297,000Source | 27,443,000Source | 108,583,000Source | 37,496,000Source | -28,727,000Source | -31,437,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 12,847,000Source | -1,002,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 23,031,000Source | 4,245,000Source | 19,405,000Source | 36,182,000Source | 8,485,000Source | 26,676,000Source | 107,522,000Source | 35,780,000Source | -26,671,000Source | -36,165,000Source |
| Income Tax Expense (Benefit)USD | — | — | -1,288,000Source | 29,000Source | 4,723,000Source | 1,275,000Source | 1,170,000Source | 994,000Source | -82,769,000Source | 316,000Source | -1,700,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 24,319,000Source | 4,216,000Source | 14,682,000Source | 34,907,000Source | 7,315,000Source | 25,682,000Source | 190,291,000Source | 35,464,000Source | -25,028,000Source | -36,231,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.71Source | 0.13Source | 0.42Source | 1.03Source | 0.21Source | 0.76Source | 5.6Source | 1.07Source | -0.77Source | -1.23Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.66Source | 0.12Source | 0.41Source | 0.92Source | 0.2Source | 0.7Source | 4.87Source | 1.01Source | -0.77Source | -1.23Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 34,112,452Source | 33,441,394Source | 34,579,980Source | 33,912,669Source | 34,384,207Source | 33,721,603Source | 33,993,468Source | 33,229,953Source | 32,517,372Source | 29,556,633Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 40,748,023Source | 35,683,952Source | 40,709,227Source | 40,558,953Source | 36,194,023Source | 39,914,487Source | 40,540,694Source | 35,216,837Source | 32,517,372Source | 29,556,633Source |
| Interest Expense (non-operating)USD | — | — | 3,491,000Source | 3,617,000Source | 7,225,000Source | 3,476,000Source | 7,170,000Source | 3,461,000Source | 13,782,000Source | 14,409,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 100,000Source | 100,000Source | — | 100,000Source | — | 100,000Source | 200,000Source | 200,000Source | 100,000Source | — |
| Capitalized Computer Software, AmortizationUSD | — | — | 400,000Source | — | 800,000Source | 400,000Source | 700,000Source | 0Source | 1,300,000Source | — | — | — |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | 29,000Source | — | — | — | — | — | — | -1,643,000Source | 66,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Gross ProfitUSD | — | — | 84,575,000Source | 60,845,000Source | 113,198,000Source | 96,589,000Source | 101,161,000Source | 88,228,000Source | 362,806,000Source | 262,081,000Source | 154,093,000Source | 65,272,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 106,352,000Source | 35,318,000Source | -27,038,000Source | -36,416,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 10,791,000Source | 3,726,000Source |
| Nonoperating Income (Expense)USD | — | — | -269,000Source | 322,000Source | -4,331,000Source | -385,000Source | -4,812,000Source | -767,000Source | -1,061,000Source | -1,716,000Source | 2,056,000Source | -4,728,000Source |
| Operating ExpensesUSD | — | — | 61,275,000Source | 56,922,000Source | 89,462,000Source | 60,022,000Source | 87,864,000Source | 60,785,000Source | 254,223,000Source | 224,585,000Source | 182,820,000Source | 96,709,000Source |
| Research and Development ExpenseUSD | — | — | 15,260,000Source | 14,266,000Source | 31,632,000Source | 15,934,000Source | 24,879,000Source | 17,160,000Source | 69,055,000Source | 55,968,000Source | 36,055,000Source | 26,812,000Source |
Filing attachments
d116447dex991.htm · 8-K · 2026-09-10
EX-99.1 2 d116447dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook Andover, Mass. - September 10, 2026 - TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief Financial Officer, effective September 21, 2026. Mr. Araujo brings more than 20 years of public-c…
Read attachment ↗tmdx-ex99_1.htm · 8-K · 2026-08-04
EX-99.1 2 tmdx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 TransMedics Reports Second Quarter 2026 Financial Results Andover, Mass. - August 4, 2026 - TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended June 30, 2026. Recent Highlights ▪ Total revenue of $189.9 million in the second quarter of 2026, …
Read attachment ↗tmdx-ex99_1.htm · 8-K · 2026-05-05
EX-99.1 2 tmdx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 TransMedics Reports First Quarter 2026 Financial Results Andover, Mass. - May 5, 2026 - TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2026. Recent Highlights ▪ Total revenue of $173.9 million in the first quarter of 2026, a 21…
Read attachment ↗